(Q44508385)
Statements
1 reference
A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer (English)
1 reference
K Bouzid
1 reference
S Khalfallah
1 reference
J Tujakowski
1 reference
B Piko
1 reference
G Purkalne
1 reference
S Plate
1 reference
P Padrik
1 reference
M Serafy
1 reference
E M Pshevloutsky
1 reference
B Boussard
1 reference
Irinotecan Study Group
1 reference
1 July 2003
1 reference
1 reference
14
1 reference
7
1 reference
1106-1114
1 reference
Identifiers
1 reference
1 reference